 |
Liposomal cyclosporin A |
|---|---|
| Trade Name | Cyclospire |
| Orphan Indication | For aerosolized administration in the prevention and treatment of lung allograft rejection and pulmonary rejection events associated with bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1998-04-30 00:00:00 |
| Sponsor | Vernon Knight, M.D.;Baylor College of Medicine, Dept. of Molecular Phy, One Baylor Plaza;Houston, Texas, 77030 |
